Which ETFs hold SK Biopharmaceuticals Co Ltd?
326030 is held by 21 of the 504 ETFs we cover. The heaviest allocation is EWY at 0.1%; among the largest funds, VEA holds 0.0% and VXUS 0.0%. The median weight across all funds holding it is 0.0%.
- Covered ETFs Holding It
- 21
- Heaviest Allocation
- 0.15%in EWY
- Median Weight
- 0.01%across funds that hold it
Funds Holding 326030(21)
| ETF | |||||||
|---|---|---|---|---|---|---|---|
| EWYiShares MSCI South Korea ETF | 0.15% | 0.59% | $26.5B | 1.23% | +70.8% | +131.2% | +15.3% |
| ESGEiShares ESG Aware MSCI EM ETF | 0.09% | 0.25% | $6.8B | 2.15% | +20.1% | +34.1% | +7.1% |
| AAXJiShares MSCI All Country Asia ex Japan ETF | 0.02% | 0.72% | $3.8B | 1.36% | +22.4% | +35.6% | +7.3% |
| DFAEDimensional Emerging Core Equity Market ETF | 0.02% | 0.29% | $9.5B | 1.80% | +20.0% | +33.0% | +9.2% |
| VPLVanguard Pacific Stock Index Fund | 0.02% | 0.07% | $8.4B | 2.66% | +25.8% | +38.9% | +10.0% |
| DFEMDimensional Emerging Markets Core Equity 2 ETF | 0.01% | 0.39% | $9.0B | 1.89% | +19.5% | +31.4% | — |
| EMXCiShares MSCI Emerging Markets ex China ETF | 0.01% | 0.25% | $23.8B | 2.03% | +31.1% | +51.2% | +11.5% |
| IEMGiShares Core MSCI Emerging Markets ETF | 0.01% | 0.09% | $156.6B | 2.25% | +19.9% | +33.4% | +7.8% |
| EEMiShares MSCI Emerging Markets ETF | 0.01% | 0.72% | $30.2B | 1.70% | +20.6% | +35.3% | +7.3% |
| DFAXDimensional World ex. U.S. Core Equity 2 ETF | 0.01% | 0.28% | $12.0B | 2.27% | +17.0% | +29.0% | — |
| ACWXiShares MSCI ACWI ex U.S. ETF | 0.01% | 0.32% | $11.7B | 2.46% | +16.6% | +28.7% | +9.3% |
| IXUSiShares Core MSCI Total International Stock ETF | 0.01% | 0.07% | $59.9B | 2.88% | +16.5% | +27.9% | +9.2% |
| VEAVanguard Developed Markets Index Fund | 0.01% | 0.03% | $235.0B | 2.49% | +17.5% | +29.9% | +10.2% |
| VSGXVanguard Esg International Stock ETF | 0.01% | 0.10% | $6.5B | 2.90% | +17.2% | +28.7% | +8.5% |
| SCHFSchwab International Equity ETF | 0.01% | 0.03% | $67.5B | 2.99% | +18.1% | +30.6% | +10.5% |
| VEUVanguard FTSE All-world Ex-us Index Fund | 0.00% | 0.04% | $69.8B | 2.48% | +16.6% | +28.4% | +9.6% |
| VXUSVanguard Total International Stock Index Fund | 0.00% | 0.05% | $161.3B | 2.51% | +16.2% | +27.8% | +9.3% |
| AVEMAvantis Emerging Markets Equity ETF | 0.00% | 0.33% | $25.8B | 1.90% | +20.6% | +33.7% | +9.9% |
| SPDWState Street® SPDR® Portfolio Developed World ex-US ETF | 0.00% | 0.03% | $40.5B | 2.94% | +17.9% | +30.1% | +10.1% |
| ACWIiShares MSCI ACWI ETF | 0.00% | 0.32% | $33.2B | 1.39% | +14.8% | +25.0% | +11.3% |
| VTVanguard Total World Stock Index Fund | 0.00% | 0.06% | $80.9B | 1.54% | +15.0% | +25.3% | +11.1% |
Expense = net expense ratio from the fund's latest SEC prospectus filing. YTD/1Y/5Y are trailing total returns including dividends (5Y annualized, as of 2026-08-07). Past performance does not predict future results. Sort by any column.
Frequently Asked Questions
Which ETF has the most 326030 exposure?
EWY has the heaviest 326030 allocation of the ETFs we cover, at 0.15% of its portfolio, based on the fund's latest SEC-reported holdings.
How many ETFs hold 326030?
21 of the 504 ETFs we cover hold SK Biopharmaceuticals Co Ltd (326030). The median weight across those funds is 0.01%.
What is the cheapest ETF that holds 326030?
VEA has the lowest expense ratio among covered ETFs holding 326030, at 0.03% per year.
What is the largest ETF that holds 326030?
VEA (Vanguard Developed Markets Index Fund) is the largest covered ETF holding 326030, with $235.0B in assets and a 0.01% position.
Keep Exploring
Look up another stock or compare two of these ETFs to see how much they overlap beyond 326030.